5 Biopharma Trends to Watch in 2019
Τop Advances in 2018 That Are Shaping Medicine
Are China’s CRISPR Clinical Trials Running off the Rails?
Biopharma in 2019
Is the Biotech Bull Market Over?
FDA Lifts Clinical Hold; Green-Lights Vertex and CRISPR’s Sickle Cell Gene Therapy Trial
FDA clears Vertex, CRISPR to test gene-editing therapy in sickle cell patients
Amicus muscles in on Pompe gene therapy chase
Gene therapy deal-making shows no signs of stopping
CRISPR Therapeutics and ViaCyte Collaborate to Tackle Type 1 Diabetes
US Companies Launch CRISPR Clinical Trial
CRISPR, Vertex launch first company-backed gene editing trial in humans
We’ve been hearing about CRISPR since 2012, and excitement has been mounting about this molecular tool that can add, remove, or exchange a DNA sequence within the genome of … Continue Reading 5 Things to Know About CRISPR
CRISPR technology offers the promise to cure any human genetic disease. Which are the candidates to be the first one? CRISPR-Cas9 was first described as a gene editing tool in … Continue Reading 7 Diseases CRISPR Technology Could Cure
In 2016, German pharma giant Bayer took a bold step and decided to partner with CRISPR Therapeutics to form a company that could join the race to be first into … Continue Reading The Race to Get CRISPR to the Clinic: Hope Versus Hype
Genomic medicine is the future of healthcare. Spawned by the Human Genome Project (“HGP”), this precise and personal approach to medicine is an emerging discipline with enormous disruptive … Continue Reading Genomic Medicine: Catch The Gene Therapy Wave